Learn proper billing for antepartum services.
The post What to Do When a Pregnant Patient Has New Insurance appeared first on AAPC Knowledge Center.
Click here for more sample CPC practice exam questions with Full Rationale Answers
Screening for Hepatitis B (HBV) infection in pregnant women provides substantial benefit, reaffirms the U.S. Preventive Services Task Force (USPSTF) in their recommendation statement released last month. This determination follows their review of new evidence on the benefits and risks of screening for hepatitis B surface antigen (HBsAg). Serologic testing accurately identifies HBV infection and, in turn, women whose infants are at risk of perinatal transmission. Interventions provided to HBV-positive pregnant women are effective in preventing perinatal transmission of HBV and the subsequent development of chronic HBV infection.
HBV Significance:
HBV is a leading cause of death worldwide. Chronic HBV infection is associated with increased morbidity and mortality, often leading to cirrhosis and liver cancer.
Prevention of mother-to-child transmission is an integral part of global efforts to mitigate the burden of chronic HBV since vertical transmission is responsible for approximately one-half of chronic infections globally.
An estimated 24,000 infants are born each year to women in the United States infected with HBV.
Although there are guidelines for universal infant HBV vaccination, rates of maternal HBV infection have increased annually by 5.5 percent since 1998. Without postexposure immunoprophylaxis, approximately 40 percent of infants born to HBV-infected mothers in the United States will develop chronic HBV infection, approximately one-fourth of whom will eventually die from chronic liver disease, according to the Centers for Disease Control and Prevention (CDC).
HBsAg Testing Saves Lives:
The CDC has recommended routine prenatal screening for hepatitis B infection since 1988. The principal screening test for detecting maternal HBV infection is the serologic identification of HBsAg. Immunoassays for detecting HBsAg have a reported sensitivity and specificity greater than 98 percent.
Prevent perinatal HBV transmission by identifying HBV-infected pregnant women via HBsAg testing and provide targeted HBV immunoglobulin (HBIG) and vaccination postdelivery for infants born to HBsAg–positive mothers.
USPSTF Reviews Substantial Evidence:
To reaffirm its 2009 recommendation on HBV screening in pregnant women, the USPSTF commissioned a reaffirmation evidence update to identify substantial new evidence sufficient enough to change the prior recommendation.
In the United States, the standard intervention for all HBV-positive pregnant women is case management. Thus, USPSTF’s evidence review focused on the benefits and risks of screening and the effectiveness and potential harms of case management in the prevention of perinatal transmission.
The net benefit of screening continues to be well established. Mounting evidence proves that serologic testing for HBsAg accurately identifies HBV infection and interventions are successful in preventing perinatal transmission. In fact, studies showed a decrease in perinatal transmission among women and infants enrolled in case management.
Source: https://www.aapc.com/blog/48069-hbsag-screening-in-pregnant-women/
Laureen shows you her proprietary “Bubbling and Highlighting Technique”
Download your Free copy of my "Medical Coding From Home Ebook" at the top right corner of this page
Tag Archives: Pregnant
Stop Hepatitis B via HBsAg Screening in Pregnant Women
Screening for Hepatitis B (HBV) infection in pregnant women provides substantial benefit, reaffirms the U.S. Preventive Services Task Force (USPSTF) in their recommendation statement released last month. This determination follows their review of new evidence on the benefits and risks of screening for hepatitis B surface antigen (HBsAg). Serologic testing accurately identifies HBV infection and, in turn, women whose infants are at risk of perinatal transmission. Interventions provided to HBV-positive pregnant women are effective in preventing perinatal transmission of HBV and the subsequent development of chronic HBV infection.
HBV Significance:
HBV is a leading cause of death worldwide. Chronic HBV infection is associated with increased morbidity and mortality, often leading to cirrhosis and liver cancer.
Prevention of mother-to-child transmission is an integral part of global efforts to mitigate the burden of chronic HBV since vertical transmission is responsible for approximately one-half of chronic infections globally.
An estimated 24,000 infants are born each year to women in the United States infected with HBV.
Although there are guidelines for universal infant HBV vaccination, rates of maternal HBV infection have increased annually by 5.5 percent since 1998. Without postexposure immunoprophylaxis, approximately 40 percent of infants born to HBV-infected mothers in the United States will develop chronic HBV infection, approximately one-fourth of whom will eventually die from chronic liver disease, according to the Centers for Disease Control and Prevention (CDC).
HBsAg Testing Saves Lives:
The CDC has recommended routine prenatal screening for hepatitis B infection since 1988. The principal screening test for detecting maternal HBV infection is the serologic identification of HBsAg. Immunoassays for detecting HBsAg have a reported sensitivity and specificity greater than 98 percent.
Prevent perinatal HBV transmission by identifying HBV-infected pregnant women via HBsAg testing and provide targeted HBV immunoglobulin (HBIG) and vaccination postdelivery for infants born to HBsAg–positive mothers.
USPSTF Reviews Substantial Evidence:
To reaffirm its 2009 recommendation on HBV screening in pregnant women, the USPSTF commissioned a reaffirmation evidence update to identify substantial new evidence sufficient enough to change the prior recommendation.
In the United States, the standard intervention for all HBV-positive pregnant women is case management. Thus, USPSTF’s evidence review focused on the benefits and risks of screening and the effectiveness and potential harms of case management in the prevention of perinatal transmission.
The net benefit of screening continues to be well established. Mounting evidence proves that serologic testing for HBsAg accurately identifies HBV infection and interventions are successful in preventing perinatal transmission. In fact, studies showed a decrease in perinatal transmission among women and infants enrolled in case management.
Source: https://www.aapc.com/blog/48069-hbsag-screening-in-pregnant-women/
Stop Hepatitis B via HBsAg Screening in Pregnant Women
Screening for Hepatitis B (HBV) infection in pregnant women provides substantial benefit, reaffirms the U.S. Preventive Services Task Force (USPSTF) in their recommendation statement released this month. This determination follows their review of new evidence on the benefits and risks of screening for hepatitis B surface antigen (HBsAg). Serologic testing accurately identifies HBV infection and, in turn, […]
The post Stop Hepatitis B via HBsAg Screening in Pregnant Women appeared first on AAPC Knowledge Center.
Admitted for other conditions found to have pregnant and underwent abortion
25 yr old female patient with metastatic biliary cancer admitted to inpatient for neoplasm related pain and after 10 days of admission patient suddenly developed severe vaginal bleeding and gyn consultation was done, ordered labs . Labs shows high BHCG levels 1,6770 IU/L. Gyn consultant documents —found to have pregnant and underwent miscarriage. how would i code this encounter ?
——————————
Anugu Srinivas
Medical Coder
Bachelor of pharmacy,CCS
Admitted for other conditions found to have pregnant and underwent abortion
25 yr old female patient with metastatic biliary cancer admitted to inpatient for neoplasm related pain and after 10 days of admission patient suddenly developed severe vaginal bleeding and gyn consultation was done, ordered labs . Labs shows high BHCG levels 1,6770 IU/L. Gyn consultant documents —found to have pregnant and underwent miscarriage. how would i code this encounter ?
——————————
Anugu Srinivas
Medical Coder
Bachelor of pharmacy,CCS
——————————
Drainage of Infected Urethral Diverticulum – 6 mos pregnant w/ twins
Does anyone know what cpt code to use for drainage of infected urethral diverticulm? I was leaning towards 10160 but not sure if accurate.
From PT’s chart –
"URETHRA: 5cm x 2cm large urethral diverticulum present. When mass was palpated, about 20ml of purulent fluid
was expressed through urethra. After obtaining permission from patient, local anesthetic was applied to the
anterior vagina and additional 5ml of purulent fluid was obtained percutaneously via needle decompression.
Resultant diverticular sac felt to be originating from midurethra with potential loculations still present
but not able to be successfully drained at present time. Bleeding noted from anterior vaginal wall puncture
sites which resolved with holding pressure."
"Today, we decompressed majority of diverticulum transurethrally and percutaneously. A straight catheterized urine culture was sent and needle aspirated fluid also sent for culture."
Thanks in advance for any help someone may offer! This is not a procedure I’ve ever coded for before!
Drainage of Infected Urethral Diverticulum – 6 mos pregnant w/ twins
I code for a Urogynecologist office, & this is a first that I’ve ever had to code for this – Does anyone know what cpt code to use for drainage of infected urethral diverticulum? I was leaning towards 10160 but not sure if accurate.
From PT’s chart –
"URETHRA: 5cm x 2cm large urethral diverticulum present. When mass was palpated, about 20ml of purulent fluid
was expressed through urethra. After obtaining permission from patient, local anesthetic was applied to the
anterior vagina and additional 5ml of purulent fluid was obtained percutaneously via needle decompression.
Resultant diverticular sac felt to be originating from midurethra with potential loculations still present
but not able to be successfully drained at present time. Bleeding noted from anterior vaginal wall puncture
sites which resolved with holding pressure."
"Today, we decompressed majority of diverticulum transurethrally and percutaneously. A straight catheterized urine culture was sent and needle aspirated fluid also sent for culture."
Thanks in advance for any help someone may offer!
Joint Commission: Test pregnant women for HIV and syphilis before childbirth
On July 1, 2018, The Joint Commission will implement three new elements of performance (EP) for maternity care. The announcement, which came in the latest R3 Report, is intended to reduce the risk of transmitting diseases like HIV and syphilis from mother to newborn.
Cpt Code for Pregnant Cardiac Arrest patient
How would I code this procedure?
DESCRIPTION OF PROCEDURE: The patient had been brought in by paramedics,
currently undergoing CPR as the patient had been found down at home. The
patient did not have a pulse and was in asystole. I had arrived at a time
after being informed of the patient about to arrive in that condition. The
patient was moved from the gurney to the ER table and a surgical tray had
been opened. I had informed the ER physician that a perimortem cesarean
section would be preferable, to be performed at that moment. There was a
low midline skin scar in the abdomen and after being gowned and gloved, I
had a time, an incision with the scalpel was made rapidly through the low
midline skin incision and fascia and into the peritoneal cavity with one
stroke. The abdomen was held open and a vertical incision was made in the
uterus, which otherwise appeared pale. The infant was immediately
delivered via vertex extraction. The cord was doubly clamped and incised.
The infant handed to the neonatologist. The placenta was delivered
manually. The uterus was inspected and otherwise appeared normal. There
appeared to be some clot attached to the omentum off to the left side and
some moderate bleeding from the upper abdomen. At that point, the uterine
incision was closed with 3-0 Vicryl suture that was available. The uterus
was not bleeding and was thin walled and adequately approximated with the
3-0 Vicryl suture. I then inspected the upper abdomen where there appeared
to be moderate amount of blood and some additional clots and blood appeared
to be coming from the left upper quadrant. I could not find any active
bleeding. The patient still was undergoing a vigorous chest compressions
and still had not had a pulse. There was the possibility of some
irregularity along the spleen and therefore, I chose to pack the left upper
quadrant with 3 laparotomy pads. I was not able to close the abdomen
because of the vigorous chest compression that would not allow sutures to
hold the incision together. I also felt that further abdominal exploration
may be needed if the patient could be stabilized. Therefore, the incision
was left open and covered with a sterile laparotomy pad. At that point,
the procedure was terminated.
Thank you in advance,
Neonatal Billing on Pregnant Mothers
I am new to Neonatal coding and I am seeing something weird. It is my understanding that a Neonatologist would only be billing for newborns within the appropriate age range. But I was informed by someone that they can also bill for services performed on a pregnant woman whose baby might be in distress. does anybody have any insight on this or where I can find more information about it. Thanks.